Financials
Reported figures only · latest: Q4 2025
CNY · US GAAP
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | CNY 454.3M | −CNY 92.8M |
|---|
| FY24 | CNY 374.6M | −CNY 308.2M |
|---|
| FY23 | CNY 520.7M | −CNY 297.7M |
|---|
| FY22 | CNY 450.1M | −CNY 489.7M |
|---|
| FY21 | CNY 443.1M | −CNY 271.4M |
|---|
| FY20 | CNY 170.1M | −CNY 310M |
|---|
| FY19 | CNY 139.8M | −CNY 307M |
|---|
| FY18 | CNY 114.2M | −CNY 234.9M |
|---|
| FY17 | CNY 91.4M | −CNY 284.3M |
|---|
| FY16 | CNY 455M | −CNY 261.9M |
|---|
| FY15 | CNY 616.5M | −CNY 78.3M |
|---|
| FY14 | CNY 606.9M | CNY 124.7M |
|---|
| FY13 | CNY 563.1M | CNY 85.9M |
|---|
| FY12 | CNY 455.7M | CNY 130.8M |
|---|
| FY11 | CNY 450.1M | −CNY 215M |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 5.7% | −57.6% | −20.4% |
|---|
| FY24 | −21.1% | −142.1% | −82.3% |
|---|
| FY23 | −14.7% | −88.9% | −57.2% |
|---|
| FY22 | −33.9% | −116.6% | −108.8% |
|---|
| FY21 | −12.8% | −103.4% | −61.2% |
|---|
| FY20 | 7.7% | −185.8% | −182.2% |
|---|
| FY19 | −11.3% | −312.8% | −219.6% |
|---|
| FY18 | 17.3% | −262.1% | −205.7% |
|---|
| FY17 | −154.9% | −231.8% | −311% |
|---|
| FY16 | 37% | −37.1% | −57.5% |
|---|
| FY15 | 42.7% | −0.9% | −12.7% |
|---|
| FY14 | 54.8% | 30.3% | 20.5% |
|---|
| FY13 | 61.3% | 27.8% | 15.3% |
|---|
| FY12 | 63.9% | 39.9% | 28.7% |
|---|
| FY11 | 64.6% | −35.8% | −47.8% |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −CNY 258.1M |
|---|
| FY24 | −CNY 548.5M |
|---|
| FY23 | −CNY 389.5M |
|---|
| FY22 | −CNY 439.7M |
|---|
| FY21 | −CNY 638.3M |
|---|
| FY20 | −CNY 397.8M |
|---|
| FY19 | −CNY 428M |
|---|
| FY18 | −CNY 204.2M |
|---|
| FY17 | −CNY 64.5M |
|---|
| FY16 | −CNY 157M |
|---|
| FY15 | −CNY 222.9M |
|---|
| FY14 | CNY 438.9M |
|---|
| FY13 | CNY 184.5M |
|---|
| FY12 | CNY 193.6M |
|---|
| FY11 | CNY 118.8M |
|---|
Returned to shareholdersDividends paid and shares bought backShow the numbers
| Year | Dividends | Buybacks |
|---|
| FY25 | - | - |
|---|
| FY24 | - | - |
|---|
| FY23 | - | - |
|---|
| FY22 | - | - |
|---|
| FY21 | - | - |
|---|
| FY20 | - | - |
|---|
| FY19 | - | - |
|---|
| FY18 | CNY 0 | CNY 0 |
|---|
| FY17 | CNY 0 | CNY 0 |
|---|
| FY16 | CNY 285.8M | CNY 30.4M |
|---|
| FY15 | CNY 0 | CNY 19.7M |
|---|
| FY14 | CNY 453.6M | - |
|---|
| FY13 | - | CNY 6M |
|---|
| FY12 | - | CNY 43.5M |
|---|
| FY11 | CNY 55.2M | CNY 6.9M |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- Concord Medical Services
- Healthcare median
Show the numbers
| Year | Concord Medical Services | Healthcare median |
|---|
| FY25 | −20.4% | −30.6% |
|---|
| FY24 | −82.3% | −47% |
|---|
| FY23 | −57.2% | −58% |
|---|
| FY22 | −108.8% | −80.4% |
|---|
| FY21 | −61.2% | −71.9% |
|---|
| FY20 | −182.2% | −62.2% |
|---|
| FY19 | −219.6% | −46.3% |
|---|
| FY18 | −205.7% | −49.6% |
|---|
| FY17 | −311% | −45.9% |
|---|
| FY16 | −57.5% | −36% |
|---|
| FY15 | −12.7% | −38.4% |
|---|
| FY14 | 20.5% | −35.5% |
|---|
| FY13 | 15.3% | −37.1% |
|---|
| FY12 | 28.7% | −29.1% |
|---|
| FY11 | −47.8% | −27.9% |
|---|